Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients

Spirometric Reference Values from a Sample of the General U.S. Population

John Hankinson, John Odencrantz, Kathleen B. Fedan · American Journal of Respiratory and Critical Care Medicine · 1999 · 4.3K citations

Health Professions, Population Health Sciences, Epidemiologic Methods +16

Some Problems in Interval Estimation

E. C. Fieller · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1954 · 1.1K citations

Natural Sciences, Mathematics, Differential Equations +9

Cystic Fibrosis Pulmonary Guidelines

Patrick A. Flume, Brian O’Sullivan, Karen A. Robinson et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 1K citations

Medicine, Clinical Sciences, Internal Medicine +9

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.

Mark J. Atkinson, Anusha Sinha, Steven Hass et al. · Health and Quality of Life Outcomes · 2004 · 996 citations · Full text

Pharmacy, Psychology, Health Assessment +16

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Steven Shak, Daniel J. Capon, Renate Hellmiss et al. · Proceedings of the National Academy of Sciences · 1990 · 716 citations

Life Sciences, Biotechnology, Molecular Biology +8